But Rybelsus also a unique selling point, being the only GLP-1 diabetes medicine sold as an oral therapy, and therefore easier to administer for patients.

Nausea, vomiting, and diarrhea are most common when first starting RYBELSUS® and when your dose increases. In studies, gastrointestinal side effects were more common in people taking RYBELSUS® than in people taking placebo, and people taking RYBELSUS® were more likely to stop treatment because of these side effects.

Rybelsus has been shown to be effective in aiding reductions in body weight. In a one-year clinical trial, those taking Rybelsus (14 mg dose, which is the higher dose) lost an average of 4.4 kilograms or about 10 pounds, even with metformin treatment for type 2 diabetes already established.

Rybelsus is meant to be used as a long-term treatment. If you and your doctor determine that Rybelsus is safe and effective for you, you'll likely take it long term. In addition to taking Rybelsus, good diet and exercise habits may help improve type 2 diabetes.

Warnings: This medication can cause a certain type of thyroid tumor (thyroid C-cell tumors) in rats. It is unknown if this medication can cause similar tumors in humans. Talk with your doctor about the benefits and risks of treatment with this medication.

Rybelsus is a long-term treatment and in most cases, it can be taken for months. As with any other medication, you should speak to your doctor to determine how safe and effective the drug is for you and make decisions accordingly.

Rybelsus is meant to be used as a long-term treatment. If you and your doctor determine that Rybelsus is safe and effective for you, you'll likely take it long term. In addition to taking Rybelsus, good diet and exercise habits may help improve type 2 diabetes.

Rybelsus is an oral tablet which is taken once a day. The usual starting dose is 3mg once daily that is given for 30 days. This is then increased to 7mg once a day for 30 days, then further increased to 14mg once a day if needed. Rybelsus tablets are formulated with salcaprozoate, which is an absorption promoter.

Acute kidney injury warning: There have been postmarketing reports of acute kidney injury and worsening of chronic renal failure, which may sometimes require hemodialysis, in patients treated with GLP-1 receptor agonists, including semaglutide.

The medication is used in combination with a healthful diet and regular exercise. You'll likely take it as a long-term treatment. Here are some fast facts about Rybelsus: Active ingredient: semaglutide.

Acute kidney injury warning: There have been postmarketing reports of acute kidney injury and worsening of chronic renal failure, which may sometimes require hemodialysis, in patients treated with GLP-1 receptor agonists, including semaglutide.

Rybelsus is a long-term treatment and in most cases, it can be taken for months. As with any other medication, you should speak to your doctor to determine how safe and effective the drug is for you and make decisions accordingly.